Lantern Pharma Inc. (LTRN)
↓ Download CSVKey ratios (FY2025)
-262.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$17.98M | -$22.22M | -$17.88M | -$14.43M | -$12.59M | — | — | — |
| Net Income | -$17.12M | -$20.78M | -$15.96M | -$14.26M | -$12.36M | -$5.91M | -$2.43M | — |
| EPS (Diluted) | $-1.57 | $-1.93 | $-1.47 | $-1.31 | $-1.13 | — | — | — |
| Total Assets | $11.04M | $25.57M | $43.65M | $58.84M | $73.95M | $20.36M | $1.43M | — |
| Total Liabilities | $4.50M | $4.38M | $2.74M | $2.80M | $2.38M | $660.8K | $489.3K | — |
| Shareholders' Equity | $6.53M | $21.19M | $40.91M | $56.04M | $71.57M | $19.70M | $943.3K | -$201.8K |
| Cash & Equivalents | $4.42M | $7.51M | $21.94M | $37.20M | $51.52M | $19.23M | $1.23M | $445.2K |
| Operating Cash Flow | -$15.68M | -$17.81M | -$14.35M | -$12.77M | -$10.59M | -$5.65M | -$2.13M | — |
| Capital Expenditures | $1.7K | $12.6K | $18.7K | $27.8K | $15.5K | — | — | — |
| Shares Outstanding | 11.25M | 10.78M | 10.72M | 10.86M | 11.09M | 6.22M | 1.98M | — |